SPRB news

Latest 1 stories · newest Nov 9, 2026

SPRB

Spruce Biosciences Eyes Dec 2026 TA-ERT BLA Filing

Spruce Anticipates Submitting its Trealesinidase Alfa BLA in December 2026 and amended its Avenue Loan to strengthen its balance sheet. The company also announced a separation of its CRHX-101 program into Adrenyx Biosciences.

Regulatory Nov 9, 2026 sentiment +0.15 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same SPRB feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/SPRB/newsSTART FREE